More on PMI
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net loss | -412.11M |
| Gain on sale of discontinued operations, net of taxes | 125.52M |
| Equity in losses from unconsolidated subsidiaries | 2.73M |
| Net realized investment gains | -713K |
| Change in fair value of certain debt instruments | -97.28M |
| Depreciation and amortization | 28.28M |
| Deferred income taxes | 98.59M |
| Compensation expense related to share-based payments | 2M |
| Deferred policy acquisition costs incurred and deferred | -11.81M |
| Amortization of deferred policy acquisition costs | 8.62M |
| Amortization of debt discount and debt issuance cost | 4.52M |
| Accrued investment income | -272K |
| Premiums receivable | 3.68M |
| Reinsurance receivables, and prepaid premiums net of reinsurance payables | 1.14M |
| Reinsurance recoverables | 67.7M |
| Prepaid and recoverable income taxes | 46.29M |
| Reserve for losses and loss adjustment expenses | 122.9M |
| Reserve for premium refunds | 22.09M |
| Unearned premiums | 3.55M |
| Related party receivables, net of payables | -109K |
| Liability for pension benefit | -2.41M |
| Note receivable | -206.57M |
| Other receivables | -2.65M |
| Other | -24.87M |
| Net cash used in operating activities from continuing operations | -221.2M |
| Proceeds from sales of fixed income securities | 203.78M |
| Proceeds from maturities of fixed income securities | 3.6M |
| Proceeds from sales of equity securities | 55.23M |
| Fixed income securities | -81.77M |
| Equity securities | -3.96M |
| Net change in short-term investments | 10.74M |
| Distributions from unconsolidated subsidiaries, net of investments | 818K |
| Capital expenditures and capitalized software, net of dispositions | -4.57M |
| Net cash provided by investing activities from continuing operations | 183.87M |
| Proceeds from issuance of convertible notes, net of issuance costs of $6,109 | 0 |
| Proceeds from issuance of common stock, net of issuance costs of $28,199 | 0 |
| Repayment of credit facility | 0 |
| Proceeds from issuance of treasury stock | 264K |
| Net cash provided by financing activities from continuing operations | 264K |
| Net cash provided by sale of discontinued operations | 25M |
| Effect of foreign exchange rate changes on cash and cash equivalents from continuing operations | 3.67M |
| Net (decrease) increase in cash and cash equivalents | -8.4M |
| Cash and cash equivalents at the beginning of the period | 267.71M |
| Cash and cash equivalents of continuing operations at end of period | 259.3M |
| Interest paid, net of capitalization | 22.25M |
| Income taxes refunds, net of payments | 45.92M |
| Income taxes payments, net of refunds | 0 |
Entities mentioned with PMI
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- Citi | View Related Stories »
- Morgan Stanley | View Related Stories »
- IPO | View Related Stories »
- Raising Prices | View Related Stories »
- Show More...
